Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Share-based Compensation (2020 - 2021)

Historic Share-based Compensation for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to $1.6 million.

  • Design Therapeutics' Share-based Compensation rose 26959.62% to $1.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.7 million, marking a year-over-year increase of 94200.0%. This contributed to the annual value of $13.1 million for FY2024, which is 12.22% down from last year.
  • Design Therapeutics' Share-based Compensation amounted to $1.6 million in Q4 2021, which was up 26959.62% from $1.2 million recorded in Q3 2021.
  • Design Therapeutics' 5-year Share-based Compensation high stood at $1.6 million for Q4 2021, and its period low was $4000.0 during Q1 2020.